Glaukos Statistics
NYSE: GKOSHealth CareMedical/Dental InstrumentsUSD
237.31-0.79 (-0.33%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Glaukos by the numbers
Glaukos has a market capitalization of $14.05 billion based on 59.20M shares outstanding. With trailing EPS of $-2.95, Glaukos is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 24.3% above its 50-day average and 57.9% above its 200-day average.
Average daily trading volume is 1.19M shares, or about $282.9 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
GKOS valuation vs. peer median
| Metric | GKOS | Peer median | Difference |
|---|---|---|---|
| Market cap | $14.05B | $9.05B | +55% |
| Forward P/E | 169.5 | 15.8 | +973% |
| Avg. volume | 1.19M | 912.52K | +31% |
Peer median across 8 companies: SOLV, BAX, PEN, PODD, GMED, TFX, HAE, MMSI.
Valuation
- Market cap
- $14.05B
- Forward P/E
- 169.50
- Price / sales (latest FY)
- 27.68
- EPS (TTM)
- $-2.95
- Shares outstanding
- 59.20M
Price and trading
- Previous close
- 238.10
- Open
- 238.87
- Day range
- 233.40 – 244.55
- 52-week range
- 93.96 – 255.19
- 52-week change
- +138.22%
- 50-day moving average
- 190.95
- 200-day moving average
- 150.33
- Beta
- —
- Volume
- 1.09M
- Average volume
- 1.19M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Oct 28, 2026
Additional statistics
- Market Cap
- 14.05B
- Forward Pe
- 169.50
- Eps
- -2.95
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 255.19
- Week52 Low
- 93.96
- Avg Volume
- 1.19M
- Shares Outstanding
- 59.20M
- Ma50
- 190.95
- Ma200
- 150.33
- Earnings Date
- Oct 28, 2026
- Pct From52w High
- -7.00%
- Pct From52w Low
- 152.56%